GELESIS
Gelesis is a clinical stage biotechnology company developing first-in-class therapeutics to safely treat obese, overweight, and diabetic patients. Gelesis100, our lead product, is an orally- administered smart pill which is constructed of materials that are General Recognized as Safe (GRAS) by the Food and Drug Administration (FDA). Each Gelesis100 capsule contains thousands of hydrogel particles approximately the size of a grain of salt that expand to 100 times their dry weight. The pill is designed to act mechanically in the stomach and small intestine to increase satiety and decrease hunger, resulting in reduced caloric intake and weight loss. Gelesis was founded in 2006 in Boston, Massachusetts
GELESIS
Industry:
Biotechnology Diabetes Health Care Medical Device
Founded:
2006-02-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.gelesis.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
312.8 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Google Tag Manager WordPress Content Delivery Network Font Awesome
Similar Organizations
BIOMODEX
BIOMODEX is a medical technology company using 3D printing to create tissue-like anatomical twins for rehearsal of surgeries.
EicOsis
EicOsis Human Health is developing a first-in-class therapy of a once daily
iCAD
iCAD develops and delivers cancer detection and radiation therapy solutions, and services that enable clinicians to find and treat cancers.
Retina Implant
Retina Implant is a biotech company which develops subretinal implants for partially sighted and blind patients.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Kennedy Lewis Investment Management
Kennedy Lewis Investment Management investment in Post-IPO Equity - Gelesis
Pritzker/Vlock Family Office
Pritzker/Vlock Family Office investment in Post-IPO Equity - Gelesis
China Medical System Holdings Limited
China Medical System Holdings Limited investment in Post-IPO Equity - Gelesis
Daphne Zohar
Daphne Zohar investment in Post-IPO Equity - Gelesis
Pimco
Pimco investment in Post-IPO Equity - Gelesis
Hambro Perks Ltd.
Hambro Perks Ltd. investment in Secondary Market - Gelesis
Vitruvian Partners
Vitruvian Partners investment in Private Equity Round - Gelesis
Cormorant Asset Management
Cormorant Asset Management investment in Private Equity Round - Gelesis
PureTech Health
PureTech Health investment in Private Equity Round - Gelesis
Pritzker/Vlock Family Office
Pritzker/Vlock Family Office investment in Private Equity Round - Gelesis
Official Site Inspections
http://www.gelesis.com Semrush global rank: 1.38 M Semrush visits lastest month: 20.81 K
- Host name: cluster027.hosting.ovh.net
- IP address: 54.36.91.62
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
More informations about "Gelesis"
Gelesis - Crunchbase Company Profile & Funding
Gelesis is a clinical stage biotechnology company developing first-in-class therapeutics to safely treat obese, overweight, and diabetic patients. Gelesis100, our lead product, is an orally- administered smart pill which is constructed of …See details»
Gelesis - Wikipedia
Gelesis is a biotechnology company located in Boston, Massachusetts that developed the weight loss device Gelesis100 (Plenity) for use in overweight and obesity. The company produces Gelesis100, which is a superabsorbent hydrogel capsule that expands in the stomach, creating a feeling of fullness, helping people reduce the amount of food they eat. The company was founded in 200…See details»
Gelesis
Gelesis is a biotechnology company developing a novel category of therapies for GI-related chronic diseases. Our superabsorbent hydrogels mimic some of the properties of raw vegetables. They are conveniently administered in capsules …See details»
Gelesis - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Gelesis . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. ... Member and Advisor Profiles 16. Contacts 53. About. Gelesis has 5 …See details»
Gelesis - LinkedIn
In April 2019, Gelesis received FDA clearance for its lead product candidate, Plenity®, as an aid for weight management in overweight and obese adults with a Body Mass Index (BMI) of 25-40 kg/m² ...See details»
Gelesis, Inc. Investor Relations
Nov 21, 2022 At Gelesis, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are …See details»
Gelesis Company Profile - Office Locations, Competitors ... - Craft
Gelesis is a biotechnology company developing therapies for weight loss and gastrointestinal-related diseases. It develops a hydrogel platform technology to treat obesity and other chronic …See details»
Gelesis Holdings Company Description - Stock Analysis
Nov 14, 2024 Gelesis Holdings, Inc. was incorporated in 2006 and is headquartered in Boston, Massachusetts. On October 30, 2023, Gelesis Holdings, Inc., along its affiliates, filed a …See details»
Gelesis - Funding, Financials, Valuation & Investors - Crunchbase
Gelesis is registered under the ticker OTCPINK:GLSHQ . Their stock opened with $10.00 in its Jan 14, 2022 IPO. Gelesis is funded by 9 investors. Salica and Vitruvian Partners are the most …See details»
Two Senior Scientific Leaders at Gelesis Awarded Top Industry …
Nov 18, 2021 The organization deemed Pash a passionate nutrition advocate and firm believer that medical affairs must be grounded in medicine and science. ... About Gelesis. Gelesis is a …See details»
Gelesis®, the Maker of Plenity® for Weight Management, Will …
Jan 13, 2022 Gelesis is a consumer-centered biotherapeutics company advancing a novel category of treatments for weight management and gut related chronic diseases. Our non …See details»
Weight management firm Gelesis to list on NYSE via SPAC deal
Jul 19, 2021 Gelesis, founded by biotech firm PureTech Health (PRTC.L), will list on the New York Stock Exchange through a merger with an acquisition vehicle, valuing the weight …See details»
PureTech Founded Entity Gelesis Announces FDA-Cleared Weight …
Dec 1, 2021 About Gelesis Gelesis is a consumer-centered biotherapeutics company advancing a novel category of treatments for weight management and gut related chronic diseases. Our …See details»
PLENITY™ BY GELESIS
Gelesis SRL - Italy PLENITY™ BY GELESIS. A hydrogel therapy. A new approach to weight management. PLENITY ® LIVE FULLER. Our lead product candidate is a first in class non …See details»
Gelesis’ Oral Treatment for Weight Management Showed Real …
Jun 26, 2023 About Gelesis. Gelesis Holdings Inc. (“Gelesis”) is a consumer-centered biotherapeutics company and the maker of Plenity®, which is inspired by nature and FDA …See details»
PureTech Founded Entity Gelesis, the Maker of Plenity
Jan 14, 2022 About Gelesis Gelesis is a consumer-centered biotherapeutics company advancing a novel category of treatments for weight management and gut related chronic …See details»
Gelesis Holdings, Inc. (GLSHQ) - Yahoo Finance
Find the latest Gelesis Holdings, Inc. (GLSHQ) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
Gelesis, a Consumer-Focused Biotherapeutics Company and the …
Jul 19, 2021 About Gelesis. Gelesis is a consumer-centered biotherapeutics company advancing a novel category of treatments for weight management and gut related chronic …See details»
Gelesis® Reports Fiscal Year 2021 Results and Fiscal Year 2022 ...
Mar 24, 2022 Gelesis provides guidance based on current market conditions and expectations for revenue, gross profit, and Adjusted EBITDA, which is a non-GAAP financial measure. …See details»
THE GI PATHWAY AND CHRONIC DISEASE - Gelesis
CONFRONTING NAFLD & NASH Within the GI pathway, the health of the epithelial barrier and mucus layer may play an important role in the treatment of nonalcoholic fatty liver disease …See details»